Silencing Paqr7 through siRNA-mediated knockdown reduced lipid accumulation and suppressed lipogenic gene expression, suggesting its role in exercise-mediated MASLD improvement. Here, PAQR7 is linked to metabolic dysfunction-associated steatotic liver disease.